Rufinamide 40 mg/mL

Rufinamide 40 mg/mL is an oral suspension used to manage certain types of seizures. This medication is designed to help control seizure activity in patients who need an effective treatment option.

Rufinamide is primarily used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome, a severe form of epilepsy. It works by stabilizing electrical activity in the brain, which can help reduce the frequency and severity of seizures. Rufinamide suspension is formulated for oral administration, making it easier to dose and administer, especially for patients who have difficulty swallowing tablets.

Common effects of Rufinamide may include dizziness, fatigue, and headache. Some users might experience nausea or vomiting. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Rufinamide should be used with caution in patients with a history of heart problems or liver disease. It is important to follow the prescribed dosage and administration instructions carefully. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Rufinamide may interact with other medications, including those that affect liver enzymes. It is important to discuss all current medications with a healthcare provider to ensure safe and effective use. Avoid consuming alcohol while taking Rufinamide, as it may increase the risk of side effects.